277 related articles for article (PubMed ID: 35940831)
1. Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol.
Copaescu AM; James F; Vogrin S; Rose M; Chua K; Holmes NE; Turner NA; Stone C; Phillips E; Trubiano J
BMJ Open; 2022 Aug; 12(8):e063784. PubMed ID: 35940831
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical Trial.
Copaescu AM; Vogrin S; James F; Chua KYL; Rose MT; De Luca J; Waldron J; Awad A; Godsell J; Mitri E; Lambros B; Douglas A; Youcef Khoudja R; Isabwe GAC; Genest G; Fein M; Radojicic C; Collier A; Lugar P; Stone C; Ben-Shoshan M; Turner NA; Holmes NE; Phillips EJ; Trubiano JA
JAMA Intern Med; 2023 Sep; 183(9):944-952. PubMed ID: 37459086
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Penicillin Allergy Clinical Decision Rule.
Trubiano JA; Vogrin S; Chua KYL; Bourke J; Yun J; Douglas A; Stone CA; Yu R; Groenendijk L; Holmes NE; Phillips EJ
JAMA Intern Med; 2020 May; 180(5):745-752. PubMed ID: 32176248
[TBL] [Abstract][Full Text] [Related]
4. Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot safety and feasibility randomised controlled trial.
Rose MT; Holmes NE; Eastwood GM; Vogrin S; James F; De Luca JF; Bellomo R; Warrillow SJ; Phung M; Barnes SL; Murfin B; Rogers B; Lambros B; Collis B; Peel TN; Slavin MA; Trubiano JA
Intensive Care Med; 2024 Jun; 50(6):913-921. PubMed ID: 38739277
[TBL] [Abstract][Full Text] [Related]
5. Penicillin allergy status and its effect on antibiotic prescribing, patient outcomes and antimicrobial resistance (ALABAMA): protocol for a multicentre, parallel-arm, open-label, randomised pragmatic trial.
Armitage KF; Porter CE; Ahmed S; Cook J; Boards J; Bongard E; Butler CC; Corfield K; Davoudianfar M; Galal U; Howard P; Mujica-Mota R; Saman R; Santillo M; Savic S; Shinkins B; Tonkin-Crine S; Wanat M; West RM; Yu LM; Pavitt S; Sandoe JAT
BMJ Open; 2023 Sep; 13(9):e072253. PubMed ID: 37666558
[TBL] [Abstract][Full Text] [Related]
6. Study protocol for PREPARE: a phase II feasibility/safety randomised controlled trial on PeRiopErative Penicillin AlleRgy TEsting.
De Luca JF; James F; Vogrin S; Chua K; Fletcher L; Nazareth J; Guha R; Hardidge A; Douglas N; Carruthers J; Stewardson A; Cheng AC; Johnson D; Douglass J; Peel T; Trubiano J
BMJ Open; 2023 Feb; 13(2):e067653. PubMed ID: 36828661
[TBL] [Abstract][Full Text] [Related]
7. Direct oral amoxicillin challenge without preliminary skin testing in adult patients with allergy and at low risk with reported penicillin allergy.
Kuruvilla M; Shih J; Patel K; Scanlon N
Allergy Asthma Proc; 2019 Jan; 40(1):57-61. PubMed ID: 30582497
[No Abstract] [Full Text] [Related]
8. Predictive factors of amoxicillin immediate hypersensitivity and validation of PEN-FAST clinical decision rule.
Piotin A; Godet J; Trubiano JA; Grandbastien M; Guénard-Bilbault L; de Blay F; Metz-Favre C
Ann Allergy Asthma Immunol; 2022 Jan; 128(1):27-32. PubMed ID: 34271183
[TBL] [Abstract][Full Text] [Related]
9. De-labelling self-reported penicillin allergy within the emergency department through the use of skin tests and oral drug provocation testing.
Marwood J; Aguirrebarrena G; Kerr S; Welch SA; Rimmer J
Emerg Med Australas; 2017 Oct; 29(5):509-515. PubMed ID: 28378949
[TBL] [Abstract][Full Text] [Related]
10. Comparing Direct Challenge to Penicillin Skin Testing for the Outpatient Evaluation of Penicillin Allergy: A Randomized Controlled Trial.
Mustafa SS; Conn K; Ramsey A
J Allergy Clin Immunol Pract; 2019; 7(7):2163-2170. PubMed ID: 31170542
[TBL] [Abstract][Full Text] [Related]
11. Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot randomised controlled trial.
Rose M; Holmes N; Eastwood G; Vogrin S; James F; Phung M; Barnes S; Murfin B; Rogers B; Lambros B; Peel T; Gibney G; Slavin M; Trubiano J
Pilot Feasibility Stud; 2023 Jul; 9(1):126. PubMed ID: 37475038
[TBL] [Abstract][Full Text] [Related]
12. Randomized Multicenter Trial for the Validation of an Easy-to-Administer Algorithm to Define Penicillin Allergy Status in Sexually Transmitted Infection Clinic Outpatients.
Lillis RA; Barbee LA; McNeil CJ; Newman L; Fortenberry JD; Alvarez-Arango S; Zenilman JM
Clin Infect Dis; 2024 May; 78(5):1131-1139. PubMed ID: 38325290
[TBL] [Abstract][Full Text] [Related]
13. Improving routine prenatal penicillin allergy testing for reported penicillin allergy.
Gill MM; Gasner S; Banken A; Park M; Weaver A; Sharpe E; Theiler R
BMJ Open Qual; 2022 Jul; 11(3):. PubMed ID: 35906008
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a pharmacist-led penicillin allergy de-labelling ward round: a novel antimicrobial stewardship intervention.
Devchand M; Kirkpatrick CMJ; Stevenson W; Garrett K; Perera D; Khumra S; Urbancic K; Grayson ML; Trubiano JA
J Antimicrob Chemother; 2019 Jun; 74(6):1725-1730. PubMed ID: 30869124
[TBL] [Abstract][Full Text] [Related]
15. The challenge of de-labeling penicillin allergy.
Stone CA; Trubiano J; Coleman DT; Rukasin CRF; Phillips EJ
Allergy; 2020 Feb; 75(2):273-288. PubMed ID: 31049971
[TBL] [Abstract][Full Text] [Related]
16. Use of oral penicillin challenge in low-risk penicillin allergy.
Drug Ther Bull; 2024 Mar; 62(4):51. PubMed ID: 38527765
[No Abstract] [Full Text] [Related]
17. Safe De-Labeling of Patients at Low Risk of Penicillin Allergy in Denmark.
Fransson S; Boel JB; Mosbech HF; Poulsen LK; Ruff S; Garvey LH
Int Arch Allergy Immunol; 2022; 183(6):640-650. PubMed ID: 35108710
[TBL] [Abstract][Full Text] [Related]
18. Skin testing and oral amoxicillin challenge in the outpatient allergy and clinical immunology clinic in pregnant women with penicillin allergy.
Kuder MM; Lennox MG; Li M; Lang DM; Pien L
Ann Allergy Asthma Immunol; 2020 Dec; 125(6):646-651. PubMed ID: 32798617
[TBL] [Abstract][Full Text] [Related]
19. Inpatient allergy delabeling of pediatric patients with low-risk penicillin allergy status through direct oral amoxicillin challenge.
Lim PPC; Moore LN; Minich NM; Wessell KR; Desai AP
Allergy Asthma Proc; 2024 Jan; 45(1):61-69. PubMed ID: 38151739
[No Abstract] [Full Text] [Related]
20. Single-step direct drug provocation testing is safe for delabelling selected non-low-risk penicillin allergy labels.
Li J; Cvetanovski V; Fernando S
Ann Allergy Asthma Immunol; 2021 Aug; 127(2):232-235. PubMed ID: 33865989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
